Neurotransmitters co-existing with VIP or PACAP

Peptides

Volumn 25, Issue 3, 2004, Pages 393-401

  Fahrenkrug, Jan ^a   Hannibal, Jens ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Co existence; Co release; Neuropeptides; Neurotransmitters; PACAP; VIP

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; NEUROTRANSMITTER; VASOACTIVE INTESTINAL POLYPEPTIDE;

AMINO ACID SEQUENCE; BIOLOGICAL RHYTHM; BRAIN REGION; CARBOXY TERMINAL SEQUENCE; CENTRAL NERVOUS SYSTEM; GASTROINTESTINAL TRACT; GENITAL SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NERVE CELL; NERVE FIBER; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW; SALIVARY GLAND; SALIVATION; SMALL INTESTINE; SMOOTH MUSCLE RELAXATION; TONGUE; UPPER RESPIRATORY TRACT;

ACETYLCHOLINE; ANIMALS; CATS; GANGLIA; GLUTAMIC ACID; HUMANS; IMMUNOHISTOCHEMISTRY; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; PEPTIDE PHI; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; VASOACTIVE INTESTINAL PEPTIDE;

EID: 2342655690     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2004.01.010     Document Type: Review

References (79)

1. Bergström A.L., Hannibal J., Hindersson P., Fahrenkrug J. Light-induced phase shift in the Syrian hamster (Mesocricetus auratus) is attenuated by the PACAP receptor antagonist PACAP6-38 or PACAP immunoneutralization. Eur. J. Neurosci. 18:2003;2552-2562
2. Brenneman D.E., Eiden L.E. Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc. Natl. Acad. Sci. U.S.A. 83:1986;1159-1162
3. Brenneman D.E., Nicol T., Warren D., Bowers L.M. Vasoactive intestinal peptide: a neurotrophic releasing agent and an astroglial mitogen. J. Neurosci. Res. 25:1990;386-394
4. Buhl T., Nilsson C., Ekblad E., Johnsen A., Fahrenkrug J. Expression of prepro-VIP derived peptides, except PHI/PHV, are expressed in the female rat anterior pituitary and increased by estrogen. Neuropeptides. 30:1996;237-247
5. Christofides N.D., Yiangou Y., Piper P.J., Ghatei M.A., Sheppard M.N., Tatemoto K., et al. Distribution of peptide histidine isoleucine in the mammalian respiratory tract and some aspects of its pharmacology. Endocrinology. 115:1984;1958-1963
6. Colwell C.S., Michel S., Itri J., Rodriguez W., Tam J., Lelievre V., et al. Disrupted circadian rhythms in VIP and PHI-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285:2003;R939-R949
7. Dussaillant M., Sarrieau A., Gozes I., Berod A., Rostene W. Distribution of cells expressing vasoactive intestinal peptide/peptide histidine isoleucine-amide precursor messenger RNA in the rat brain. Neuroscience. 50:1992;519-530
8. Ebling F.J. The role of glutamate in the photic regulation of the suprachiasmatic nucleus. Prog. Neurobiol. 50:1996;109-132
9. Fahrenkrug J. Co-existence and co-secretion of the structurally related peptides VIP and PHI. Scand. J. Clin. Lab. Invest. 47:1987;43-50
10. Fahrenkrug J. Transmitter role of vasoactive intestinal peptide. Pharmacol. Toxicol. 72:1993;354-363
11. Fahrenkrug J., Bek T., Lundberg J.M., Hökfelt T. VIP and PHI in cat neurons: co-localization but variable tissue content possibly due to differential processing. Regul. Pept. 12:1985;21-34
12. Fahrenkrug J., Buhl T., Hannibal J. Prepro-PACAP-derived peptides occur in VIP-producing tumours and co-exist with VIP. Regul. Pept. 58:1995;89-98
13. Fahrenkrug J., Hannibal J. Pituitary adenylate cyclase activating polypeptide innervation of the rat female reproductive tract and the associated paracervical ganglia: effect of capsaicin. Neuroscience. 73:1996;1049-1060
14. Fahrenkrug J., Hannibal J. PACAP immunoreactivity in capsaicin-sensitive nerve fibres supplying the rat urinary tract. Neuroscience. 83:1998;1261-1272
15. Fahrenkrug J., Hannibal J., Tams J., Georg B. Immunohistochemical localization of the VIP1 receptor (VPAC1R) in rat cerebral blood vessels: relation to PACAP and VIP containing nerves. J. Cereb. Blood Flow Metab. 20:2000;1205-1214
16. Fredholm B.B., Lundberg J.M. VIP-induced cyclic AMP formation in the cat submandibular gland. Potentiation by carbacholine. Acta Physiol. Scand. 114:1982;157-159
17. Girard B.M., May V., Bora S.H., Fina F., Braas K.M. Regulation of neurotrophic peptide expression in sympathetic neurons: quantitative analysis using radioimmunoasay and real-time quantitative polymerase chain reaction. Regul. Pept. 109:2002;89-101
18. Gressens P., Hill J.M., Paindaveine B., Gozes I., Fridkin M., Brenneman D.E. Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse. J. Clin. Invest. 94:1994;2020-2027
19. Hannibal J. Neurotransmitters of the retino-hypothalamic tract. Cell Tissue Res. 309:2002;73-88
20. Hannibal J. Pituitary adenylate cyclase-activating peptide in the rat central nervous system: an immunohistochemical and in situ hybridization study. J. Comp. Neurol. 453:2002;389-417
21. Hannibal J., Brabet P., Jamen F., Nielsen H.S., Journot L., Fahrenkrug J. Dissociation between light induced phase shift of the circadian rhythm and clock gene expression in mice lacking the PACAP type 1 receptor (PAC1). J. Neurosci. 21:2001;4883-4890
22. Hannibal J., Ekblad E., Mulder H., Sundler F., Fahrenkrug J. Pituitary adenylate cyclase activating polypeptide (PACAP) in the gastrointestinal tract of the rat: distribution and effects of capsaicin or denervation. Cell Tissue Res. 291:1998;65-79
23. Hannibal J., Fahrenkrug J. Expression of pituitary adenylate cyclase activating polypeptide (PACAP) gene by rat spermatogenic cells. Regul. Pept. 55:1995;111-115
24. Hannibal J, Hindersson P, Knudsen SM, Georg B, Fahrenkrug J. The photopigment melanopsin is exclusively present in PACAP containing retinal ganglion cells of the retinohypothalamic tract. J Neurosci 2002;22(RC191):1-7.
25. Hannibal J., Mikkelsen J.D., Clausen H., Holst J.J., Wulff B.S., Fahrenkrug J. Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus. Regul. Pept. 55:1995;133-148
26. Hannibal J., Moller M., Ottersen O.P., Fahrenkrug J. PACAP and glutamate are co-stored in the retinohypothalamic tract. J. Comp. Neurol. 418:2000;147-155
27. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R., et al. International union of pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol. Rev. 50:1998;265-270
28. Harmar A.J., Marston H.M., Shen S., Spratt C., West K.M., Sheward W.J., et al. The VPAC(2) receptor is essential for circadian function in the mouse suprachiasmatic nuclei. Cell. 109:2002;497-508
29. Hill J.M., Gozes I., Hill J.L., Fridkin M., Brenneman D.E. Vasoactive intestinal peptide antagonist retards the development of neonatal behavours in the rat. Peptides. 12:1991;187-192
30. Holst J.J., Fahrenkrug J., Knuthsen S., Jensen S.L., Nielsen O.V., Lundberg J.M., et al. VIP and PHI in the pig pancreas: coexistence, corelease and cooperative effects. Am. J. Physiol. 252:1987;6182-6189
31. Hökfelt T., Holets V.R., Staines W., Meister B., Melander T., Schalling M., et al. Coexistence of neuronal messengers - an overview. Prog. Brain Res. 68:1986;33-70
32. Inoue T., Kato Y., Koshiyama H., Yanaihara N., Imura H. Interaction between vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI) in stimulating the secretion of prolactin from rat anterior pituitary cells in vitro. Neurosci. Lett. 85:1988;363-369
33. Itoh N., Obata K., Yanaihara N., Okamoto H. Human prepro-vasoactive intestinal polypeptide contains a novel PHI-27 like peptide, PHM-27. Nature. 304:1983;547-549
34. Kimura C., Ohkubo S., Ogi K., Hosoya M., Itoh Y., Onda H., et al. A novel peptide which stimulates adenylate cyclase: molecular cloning and characterization of the ovine and human cDNAs. Biochem. Biophys Res. Commun. 1:1990;81-89
35. Kitada C, Watanabe T, Masuda Y, Ohkubo S, Onda H, Fujino M. Biological activity of the segment of PACAP precursor protein. In: Proceedings of the 2nd Japan Symposium on Peptide Chemistry; 1992. p. 393-5.
36. Klein DC, Moore RY, Reppert SM. Suprachiasmatic nucleus. The mind's clock. New York: Oxford University Press; 1991.
37. Klimaschewski L., Unsicker K., Heym C. Vasoactive intestinal peptide but not galanin promotes survival of neonatal rat sympathetic neurons and neurite outgrowth of PC12 cells. Neurosci. Lett. 195:1995;133-136
38. Lioudyno M., Skoglösa Y., Takei N., Lindholm D. Pituitary adenylate cyclase-activating polypeptide (PACAP) protects dorsal root ganglion neurons from death and induces calcitonin gene-related peptide (CGRP) immunoreactivity in vitro. J. Neurosci. Res. 51:1998;243-256
39. Lorén I., Emson P.C., Fahrenkrug J., Björklund A., Alumets J., Håkanson R., et al. Distribution of vasoactive intestinal polypeptide in the rat and mouse brain. Neuroscience. 4:1979;1953-1976
40. Lundberg J.M., Fahrenkrug J., Hökfelt T., Martling C.-R., Larsson O., Tatemoto K., et al. Co-existence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man. Peptides. 5:1984;593-606
41. Lundberg J.M., Fahrenkrug J., Larsson O., Änggård A. Co-release of vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI) in relation to atropine-resistant vasodilation in cat submandibular salivary gland. Neurosci. Lett. 52:1984;37-42
42. Lundberg J.M., Fried G., Fahrenkrug J., Holmstedt B., Hökfelt T., Lagercrantz H., et al. Subcellular fractionation of a cat submandibular gland: comparative studies on the distribution of acetylcholine and vasoactive intestinal polypeptide (VIP). Neuroscience. 6:1981;1001-1010
43. Lundberg J.M., Hedlund B., Bartfai T. Vasoactive intestinal polypeptide enhances muscarinic ligand binding in cat submandibular salivary gland. Nature. 295:1982;147-149
44. Lundberg JM, Hedlund B, Änggård A, Fahrenkrug J, Hökfelt T, Tatemoto K, et al. Costorage of peptides and classical transmitters in neurons. In: Bloom SR, Polak JM, Lindenlaub E, editors. Systemic role of regulatory peptides. Stuttgart: Schattauer-Verlag; 1982. p. 93-119.
45. Lundberg J.M., Änggård A., Emson P., Fahrenkrug J., Hökfelt T. VIPergic and cholinergic mechanisms in the cat nasal mucosa: studies on choline acetyltransferase and release of VIP. Proc. Natl. Acad. Sci. U.S.A. 78:1981;5255-5259
46. Lundberg J.M., Änggård A., Fahrenkrug J., Hökfelt T., Mutt V. Vasoactive intestinal polypeptide (VIP) in cholinergic neurons of exocrine glands: functional significance of coexisting transmitters for vasodilation and secretion. Proc. Natl. Acad. Sci. U.S.A. 77:1980;1651-1655
47. Läuffer J.M., Modlin I.R., Tang L.H. Biological relevance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the gastrointestinal tract. Regul. Pept. 84:1999;1-12
48. Mikkelsen J.D., Fahrenkrug J. Concentrations and distribution of vasoactive intestinal peptide (VIP), peptide histidine isoleucine (PHI) and peptide histidine valine (PHV) in the cerebral cortex and the suprachiasmatic nucleus of the mouse brain. Brain Res. 656:1994;95-107
49. Mikkelsen J.D., Hannibal J., Fahrenkrug J., Larsen P.J., Olcese J., McArdle C. Pituitary adenylate cyclase activating peptide-38 (PACAP-38), PACAP-27, and PACAP related peptide (PRP) in the rat mediam eminence and pituitary. J. Neuroendocrinol. 7:1995;47-55
50. Miyata A., Arimura A., Dahl R.R., Uehara A., Jiang L., Culler M.D., et al. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys Res. Commun. 164:1989;567-574
51. Moore R.Y., Speh J.C., Card J.P. The retinohypothalamic tract originates from a distinct subset of retinal ganglion cells. J. Comp. Neurol. 352:1995;351-366
52. Moriarty K.J., Hegarty J.E., Tatemoto K., Mutt V., Christofides N.D., Bloom S.R., et al. Effect of peptide histidine isoleucine on water and electrolyte transport in the human jejunum. Gut. 25:1984;624-628
53. Mulder H., Uddman R., Moller K., Elsås T., Ekblad E., Alumets J., et al. Pituitary adenylate cyclase activating polypeptide is expressed in autonomic neurons. Regul. Pept. 59:1995;121-128
54. Nishizawa M., Hayakawa Y., Yanaihara N., Okamoto H. Nucleotide sequence divergence and functional constraint in VIP precursor mRNA evolution between human and rat. FEBS Lett. 183:1985;55-59
55. Ogi K., Kimura C., Onda H., Arimura A., Fujino M. Molecular cloning and characterization of cDNA for the precursor of rat pituitary adenylate cyclase activating polypeptide (PACAP). Biochem. Biophys. Res. Commun. 173:1990;1271-1279
56. Okazaki K., Itoh Y., Ogi K., Ohkubo S., Onda H. Characterization of murine PACAP mRNA. Peptides. 16:1995;1295-1299
57. Palle C., Ottesen B., Fahrenkrug J. Peptide histidine valine (PHV) is present and biologically active in the human female genital tract. Regul. Pept. 38:1992;101-109
58. Palle C., Ottesen B., Jørgensen J., Fahrenkrug J. Peptide histidine methionine and vasoactive intestinal peptide: occurrence and relaxant effect in the human female reproductive tract. Biol. Reprod. 41:1989;1103-1111
59. Pincus D.W., DiCicco-Bloom E.M., Black I.B. Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts. Nature. 343:1990;564-567
60. Portbury A.L., McConalogue K., Furness J.B., Young H.M. Distribution of pituitary adenylyl cyclase activating peptide (PACAP) immunoreactivity in neurons of the guinea-pig digestive tract and their projections in the ileum and colon. Cell Tissue Res. 279:1995;385-392
61. Reppert S.M., Weaver D.R. Coordination of circadian timing in mammals. Nature. 418:2002;935-941
62. Said S.I., Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science. 169:1970;1217-1218
63. Skakkebæk M., Hannibal J., Fahrenkrug J. Pituitary adenylate cyclase activating polypeptide (PACAP) in the rat mammary gland. Cell Tissue Res. 298:1999;153-159
64. Sundler F., Ekblad E., Hannibal J., Moller K., Zhang Y.Z., Mulder H., et al. Pituitary adenylate cyclase activating peptide in sensory and autonomic ganglia: localization and regulation. Ann. N.Y. Acad. Sci. 805:1996;410-428
65. Suzuki Y., Satoh S., Lederis K., Rorstad O. Cerebral vascular effects of peptide histidine methionine in canine and bovine species. Pharmacology. 42:1991;241-245
66. Tapia-Arancibia L., Reichlin S. Vasoactive intestinal peptide and PHI stimulate somatostatin release from rat cerebral cortical and diencephalic cells in dispersed cell culture. Brain Res. 336:1988;67-72
67. Tatemoto K., Mutt V. Isolation and characterization of the intestinal peptide procine PHI (PHI-27), a new member of the glucagon-secretin family. Proc. Natl. Acad. Sci. U.S.A. 78:1981;6603-6607
68. Tornøe K., Hannibal J., Georg B., Schmidt P.T., Hilsted L., Fahrenkrug J., et al. PACAP 1-38 as neurotransmitter in the porcine antrum. Regul. Pept. 101:2001;109-121
69. Tornøe K., Hannibal J., Jensen T.B., Georg B., Rickelt L.F., Andreasen M.B., et al. PACAP-(1-38) as neurotransmitter in the porcine adrenal glands. Am. J. Physiol. Endocrinol Metab. 279:2000;E1413-E1425
70. Tse D.L.Y., Pang R.T.K., Wong A.O.L., Chan S.-M., Vaudry H., Chow B.K.C. Identification of a potential receptor for both peptide histidine isoleucine and peptide histidine valine. Endocrinology. 143:2002;1327-1336
71. Uddman R., Luts A., Arimura A., Sundler F. Pituitary adenylate cyclase-activating peptide (PACAP), a new vasoactive intestinal peptide (VIP)-like peptide in the respiratory tract. Cell Tissue Res. 265:1991;197-201
72. Vaudry D., Gonzalez B.J., Basille M., Anouar Y., Fournier A., Vaudry H. Pituitary adenylate cyclase-activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway. Neuroscience. 84:1998;801-812
73. Vaudry D., Gonzalez B.J., Basille M., Yon L., Fournier A., Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol. Rev. 52:2000;269-324
74. White D.M., Mansfield K. Vasoactive intestinal polypeptide and neuropeptide Y act indirectly to increase neurite outgrowth of dissociated dorsal root ganglion cells. Neuroscience. 73:1996;881-887
75. Wray V., Nokihara K., Naruse S., Ando E., Kakoschke C., Wei M. Synthesis solution structure and biological action of PACAP-related peptide. Biomed. Pept. Proteins Nucleic Acids. 1:1995;77-82
76. Yiangou Y., Christofides N.D., Gu J., Blank M.A., Polak J.M., Bloom S.R. Peptide histidine methionine (PHM) and the human male genitalia. Neuropeptides. 6:1985;133-142
77. Yiangou Y., DiMarzo V., Spokes R.A., Panico M., Morris H.R., Bloom S.R. Isolation, characterization and pharmacological actions of peptide histidine valine 42, a novel preprovasoactive intestinal peptide-derived peptide. J. Biol. Chem. 262:1987;14010-14013
78. Yuwiler A., Brammer G.L., Bennett B.L. Commonalities in vasoactive intestinal peptide and peptide N-terminal histidine C-terminal isoleucine stimulation of N-acetyltransferase activity in the rat pineal. J. Pineal Res. 15:1993;81-87
79. Zhang Q., Shi T.-S., Ji R.-R., Zhang Y., Sundler F., Hannibal J., et al. Expression of pituitary adenylate cyclase-activating polypeptide in dorsal root ganglia following axotomy: time course and coexistence. Brain Res. 705:1995;149-158